Effects of angiotensin-converting enzyme gene polymorphism on the left-ventricular function and mass in patients with acromegaly

Cardiology

Volumn 92, Issue 4, 1999, Pages 226-231

  Erbas, Tomris ^a   Alikasifoglu, Mehmet ^a   Aksöyek, Serdar ^a   Unsal, Ibrahim ^a   Gedik, Olcay ^a   Tuncbilek, Ergül ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acromegaly; Angiotensin converting enzyme gene polymorphism; Ventricular dysfunction; Ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GROWTH HORMONE;

ACROMEGALY; ADULT; ALLELE; ARTICLE; BLOOD ANALYSIS; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE DURATION; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; GENOTYPE; GROWTH HORMONE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; SYSTOLE;

EID: 0033505057     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006978     Document Type: Article

References (32)

1. Rajasoorya C, Holdaway IM, Wringtson P, Scott DJ, Ibbertson HK: Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994;41:95-102.
2. Sacca L, Cittadini A, Fazio S: Growth hormone and the heart. Endocr Rev 1994;15:553-573.
3. Ezzat S, Forster MJ, Berchtold P, Redelmeier D, Boerlin V, Harris AG: Acromegaly: Clinical and biochemical features in 500 patients. Medicine 1994;73:233-240.
4. Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J: Arrhythmia profile in acromegaly. Eur Heart J 1992;13:51-56.
5. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardini D, Sacca L: Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994;79:441-446.
6. Erbas T, Erbas B, Usman A, Bekdik CF: Assessment of left ventricular dsyfunction in acroniegalic patients using radionuclide ventriculography parameters. Cardiology 1992;80: 172-179.
7. Morgan HE, Baker KM: Cardiac hypertrophy: Mechanical, neural and endocrine dependence. Circulation 1991;83:13-25.
8. Rigat B, Hubert C, Alhene-Gelas F, Cambien F, Covol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343-1346.
9. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB: Angiotensin-converting enzyme DD genotype in patients with isehaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-1075.
10. Marian AJ, Yu Q, Workman R, Gottfried G, Roberts R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342:1085-1086.
11. Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A, Malatesta P, Perrotti N, Tramontano D, Mattioli PL: Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol 1997;29:365-369.
12. Sahn DJ, De Maria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;54:1072-1083.
13. Devereux RB: Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardisation and comparison to other methods. Hypertension 1987;9 (suppl 2):ii19-ii26.
14. Reicheck N, Wilson J, St John Sutton M, Plappert TA, Goldberg S, Hirshfeld JW: Non-invasive determination of left ventricular end-systolic stress: Validation of the method and initial application. Circulation 1982;65:99-108.
15. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, La Motte F, Buring J. Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
16. Daemon MJAP, Lombardini DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-456.
17. Itoh H, Mukoyama M, Pratt RE, Gibbons GE, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91:2268-2274.
18. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
19. Costerousse O, Allegrini J, Lopez M, Alhene-Gelas F: Angiotensin 1-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
20. Beneteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J: Serum angiotensin-converting enzyme in healthy and sarcoidotic children: Comparison with the reference interval for adults. Clin Chem 1990;36:344-346.
21. Tiret L, Brigitte R, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin 1-converting enyzme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
22. Bloem LJ, Manatunga AK, Pratt JH: Racial difference in the relationship of an angiotensin 1-converting enzyme gene polymorphism to serum angiotensin 1-converting enzyme activity. Hypertension 1996;27:62-66.
23. Cambien F, Poirier O, Lecerf L, Evans AE, Cambou JP, Arveiler D, Luc G, Band JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhene-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
24. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borech-Johnsen K, Parving HH: Insertion/deletion polymorphism in the angiotensin-1-converting enyzme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38:798-803.
25. Ruiz J, Blanche H, Cohen N: Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
26. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H: Angiotensin-converting enyzme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92: 1387-1388.
27. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ: Association between a deletion polymorphism of the angiotensin-converting-enyzme gene and left ventricular hypertrophy. N Engl J Med 1994;3311:1634-1638.
28. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA: Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 1996;77:1315-1319.
29. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Bobola N, Ravazzolo R, Sacchi G, Deferrari G: The deletion polymorphism of the angiotensin 1-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996;7:2550-2558.
30. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ: Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994;267(3 pt 2):H1107-H1111.
31. Lindpainter K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PW, Vasan RS, Myers RH, Levy D: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996;334:1023-1028.
32. Lopez-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM, Moya-Mur JL, Garcia-Robles R: Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension. J Clin Endocrinol Metab 1997;82:1047-1053.